Stocks making the biggest moves midday: SpaceX, GE Vernova, Crinetics Pharmaceuticals, Rivian & more
Midday movers included Cognizant (+6%) expanding its Google Cloud partnership for Gemini AI; USA Rare Earth (-7%) amid a WSJ report of expanded congressional inquiry into its $1.6B investment; Adobe (+5%) after BofA reinstated coverage with a $190 target. GE Vernova (-10%) and other AI/semis fell on selloffs; SpaceX (-5%) began Nasdaq-100 trading. Vertex agreed to buy Crinetics in a $10B deal. Rivian (-14%) announced a 75M-share raise.
How this was made
The 30-second read
Why it matters
The most tradable, company-specific catalysts in the text are Rivian’s 75M-share capital raise, the Vertex–Crinetics $10B acquisition, and Fiserv’s reported payments-infrastructure sale discussions; other names are mostly explained by sector tape moves.
Market read
Traders can use the deal/capital-raise headlines for near-term positioning, while the rest of the list mainly reflects correlated sector risk appetite.
What to watch
For capital raises and acquisitions, the market reaction may hinge on undisclosed terms (pricing, financing, integration timeline) not provided in this wrap.
Background
This is a midday multi-stock market wrap highlighting movers across AI infrastructure, software, semiconductors, space, quantum, and select corporate actions/deal headlines.
Ticker impact
Rivian shares slid 14% after the company announced a 75 million-share capital raise plus revenue and delivery guidance.
Likely continued volatility as investors price dilution; guidance beat may limit downside but not erase the raise impact.
The article cites both the size of the new share sale (75M) and the immediate market reaction (down 14%), indicating the raise drove sentiment more than the beat.
Crinetics shares roughly doubled after Vertex agreed to buy Crinetics in a $10 billion deal to expand rare hormonal disease treatments.
Near-term upside bias toward deal completion, with typical M&A headline-driven volatility.
The article explicitly states the $10B acquisition and the immediate ~doubling in Crinetics shares.
Vertex agreed to buy Crinetics in a $10 billion deal; Vertex shares dipped about 1% on the announcement.
Choppy trading around deal details; direction likely depends on financing terms and regulatory/timeline expectations.
The article provides the deal size and the immediate ~-1% move but no financing specifics, limiting conviction on longer-horizon impact.
GE Vernova stock tanked 10% as AI infrastructure plays sold off, dragging related names in the same tape.
Near-term downside pressure likely persists while AI-infrastructure sentiment remains weak.
The article attributes the drop to a broader selloff, not a new GE Vernova-specific disclosure.
Palantir shares added 2% during midday trading as software stocks were a rare bright spot in the tech sector.
Limited standalone follow-through expected unless a company-specific catalyst emerges.
No Palantir-specific news is provided beyond the intraday move and sector context.
Salesforce shares rose 3% midday as software stocks were described as a rare bright spot in the tech sector.
May track broader software sentiment; stock-specific upside requires additional catalysts.
The text provides only the intraday percentage move and sector framing.
Intuitive Machines shares declined more than 6% midday as other space stocks fell following SpaceX’s Nasdaq-100 first-day trading.
Likely to remain correlated with space-sector sentiment.
No Intuitive Machines-specific news is disclosed in the text.
AST SpaceMobile shares fell more than 6% midday as space stocks dropped after SpaceX’s first day trading in the Nasdaq-100.
Near-term downside bias if the selloff persists across space names.
The article provides only the intraday move and the SpaceX/Nasdaq-100 context.
Market effects
AI infrastructure and quantum/space names sold off together, while software held up, signaling a rotation within tech.
Korea chip-heavy indices fell sharply, reinforcing a broader semiconductor risk-off impulse.
Cross-asset read-through from AI/semis weakness can pressure global growth-sensitive equities beyond the named stocks.
Counterpoint
Some moves (e.g., software strength, deal-driven biotech) may be temporary tape effects; the broader AI/semis selloff could reverse if macro/earnings catalysts stabilize.
Key entities
- companyRivian
Announced a 75 million-share capital raise and issued guidance that beat consensus, yet shares fell 14%.
- companyVertex Pharmaceuticals
Agreed to buy Crinetics in a $10B deal to expand rare hormonal disease treatments.
- companyCrinetics Pharmaceuticals
Shares roughly doubled on the $10B acquisition agreement by Vertex.
- companyFiserv
Reportedly discussed selling its payments infrastructure business to major U.S. banks.
- companyCaterpillar
Agreed to buy Skycatch, with deal terms undisclosed.
